Pharma News

The latest developments from pharmaceutical and biopharmaceutical companies, both innovator and generic-drug companies, and leading regulatory news.

Celgene plans to open the Thomas O. Daniel Research Incubator and Collaboration Center to provide entrepreneurs laboratory space and resources and support scientists and companies to accelerate medical discoveries and innovations. The facility...

Pfizer has formed a clinical trial collaboration with Kite Pharma, Gilead Sciences’ cell-therapy subsidiary, to evaluate the investigational combination of Gilead’s Yescarta (axicabtagene ciloleucel), a chimeric antigen receptor T cell (CAR T)...

Sandoz, the generics arm of Novartis, has partnered with Biocon, a Bangalore, India-based pharmaceutical company, to develop, manufacture, and commercialize multiple biosimilars in immunology and oncology. Under the agreement, both companies will...

Celgene has agreed to acquire Juno Therapeutics, a Seattle, Washington biopharmaceutical company developing cancer immunotherapies, for approximately $9 billion. Under the agreement, Celgene will pay $87 per share in cash, or a total of...

The UK Medicines and Healthcare products Regulatory Agency (MHRA) has issued an update for pharmaceutical companies on scenarios regarding pharmaceutical regulation dependent on the implementation plan of the UK exiting the European Union (EU)...

Eisai has completed construction of a new oral solid-dosage (OSD) production facility and an administration building at the site of its new Suzhou, China plant located within the Suzhou Industrial Park. The newly completed OSD production facility...

The UK Medicines and Healthcare products Regulatory Agency (MHRA) has issued to Inner Mongolia Changsheng Pharmaceutical, a Hohhot, China-headquartered pharmaceutical company, a statement of non-compliance with good manufacturing practice (GMPs)...

A roundup of the latest market developments from the pipelines of the pharmaceutical majors, featuring news from Novartis. Editor's Note: This article was updated on a continuous basis for news announced from Wednesday, January 10, 2017 to...